Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.
about
Prevention of pertussis through adult vaccinationVaccine responsiveness in the elderly: best practice for the clinic.Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old.Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.Cost-Effectiveness of the 4 Pillars Practice Transformation Program to Improve Vaccination of Adults Aged 65 and Older.Clinical characteristics and pertussis costs in cases reported to epidemiological services and cases detected in household contacts in Catalonia (Spain).Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis.Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis.
P2860
Q35896233-1B254B4B-5BD4-4B4B-BF7B-451C7BE95EFDQ38217108-C56B86EE-83E1-4607-BBEA-5CC07483C678Q38614227-B1943580-E212-40A7-AC7E-198D992F5A53Q38626455-75F8E465-E955-4916-B249-79E1186DC2E8Q39064272-FD057441-D805-4195-B73D-E8A279A9944FQ40156865-5BB54B9E-C5BF-4932-826E-A4380BF09266Q47325042-796EAE66-BE9F-443C-BFA5-A6A3DB2DD14DQ48164516-1867A6E5-ECF9-4945-9205-1CFB85B3B8AC
P2860
Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of Tdap vac ...... model of disease transmission.
@en
Cost-effectiveness of Tdap vac ...... model of disease transmission.
@nl
type
label
Cost-effectiveness of Tdap vac ...... model of disease transmission.
@en
Cost-effectiveness of Tdap vac ...... model of disease transmission.
@nl
prefLabel
Cost-effectiveness of Tdap vac ...... model of disease transmission.
@en
Cost-effectiveness of Tdap vac ...... model of disease transmission.
@nl
P2093
P2860
P50
P1433
P1476
Cost-effectiveness of Tdap vac ...... model of disease transmission.
@en
P2093
Bhakti Arondekar
Cristina Masseria
Girishanthy Krishnarajah
Gregory Hill
Julie Roiz
Michelle Skornicki
Narin Pruttivarasin
P2860
P304
P356
10.1371/JOURNAL.PONE.0072723
P407
P577
2014-01-09T00:00:00Z